BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,995,836 | -2.3% | 124,567 | +29.7% | 0.00% | 0.0% |
| Q2 2023 | $3,066,717 | +28.3% | 96,045 | +23.0% | 0.00% | +50.0% |
| Q1 2023 | $2,390,534 | -17.7% | 78,071 | +5.1% | 0.00% | -33.3% |
| Q4 2022 | $2,904,542 | +5.4% | 74,266 | +28.3% | 0.00% | 0.0% |
| Q3 2022 | $2,757,000 | +31.5% | 57,868 | +6.9% | 0.00% | +50.0% |
| Q2 2022 | $2,096,000 | -19.1% | 54,143 | +19.7% | 0.00% | 0.0% |
| Q1 2022 | $2,591,000 | -40.2% | 45,224 | -16.8% | 0.00% | 0.0% |
| Q4 2021 | $4,333,000 | -75.1% | 54,373 | -72.8% | 0.00% | -80.0% |
| Q3 2021 | $17,402,000 | +366.5% | 199,983 | +590.3% | 0.01% | +400.0% |
| Q2 2021 | $3,730,000 | +95.8% | 28,969 | +21.7% | 0.00% | +100.0% |
| Q1 2021 | $1,905,000 | -60.3% | 23,801 | -59.5% | 0.00% | -50.0% |
| Q4 2020 | $4,794,000 | +2099.1% | 58,728 | +565.8% | 0.00% | – |
| Q3 2020 | $218,000 | – | 8,821 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |